InFLAMES Flagship
- Targeted destruction of follicle stimulating hormone receptor-positive cancer cells in vitro and in vivo by a lytic peptide Phor21-FSHβ conjugateTau-targeting antisense oligonucleotide MAPTRx in mild Alzheimer’s disease: a phase 1b, randomized, placebo-controlled trial (2025)
- Targeted serum proteomics of longitudinal samples from newly diagnosed youth with type 1 diabetes affirms markers of diseaseT cell immunity following COVID-19 vaccination in adult patients with primary antibody deficiency - a 22-month follow-up (2025)
- Targeted serum proteomics of longitudinal samples from newly diagnosed youth with type 1 diabetes distinguishes markers of disease and C-peptide trajectoryTEDDY luo toivoa (2023)
- Targeting sex steroid biosynthesis for breast and prostate cancer therapyTekonivelinfektion riskitekijät ensivaiheen lonkan tekonivelleikkauksen jälkeen (2023)
- Target-specific compound selectivity for multi-target drug discovery and repurposing (2022)
- Targetting folate receptor-β expressing macrophages by 18F-labelled folate PET radiotracer in rat model of myocardial infarction (2022)
- (2024)
- (2023)
- (2021)
- (2022)





